Literature DB >> 20943436

Quantifying muscle asymmetries in cervical dystonia with electrical impedance: a preliminary assessment.

Codrin Lungu1, Andrew W Tarulli, Daniel Tarsy, Phillip Mongiovi, Veronique G Vanderhorst, Seward B Rutkove.   

Abstract

OBJECTIVE: Cervical dystonia (CD) lacks an objective quantitative measure. Electrical impedance myography (EIM) is a non-invasive assessment method sensitive to changes in muscle structure and physiology. We evaluate the potential role of EIM in quantifying CD, hypothesizing that patients would demonstrate differences in the symmetry of muscle electrical resistance compared to controls, and that this asymmetry would decrease after botulinum neurotoxin (BoNT) treatment.
METHODS: EIM was performed on the sternocleidomastoid (SCM) and cervical paraspinal (PS) muscles of CD patients and age-matched controls. 50 kHz resistance was analyzed, comparing side-to-side asymmetry in patients and controls, and, in patients, before and after BoNT treatment.
RESULTS: Sixteen patients and 10 controls were included. Resistance asymmetry was on average 3-5 times higher in patients than controls. Receiver operating characteristic analysis demonstrated 91% accuracy of discriminating CD from normal. From pre-treatment to maximum BoNT effect, asymmetry decreased from 20.8(13.9-26.1)% to 6.2(3.1-9.9)% (SCM), and from 16.0(14.3-16.0)% to 8.4(7.0-9.2)% (PS), p<0.05 (median, interquartile range).
CONCLUSIONS: EIM effectively differentiates normal subjects from CD patients by revealing asymmetries in resistance values and detects improvement in muscle symmetry after treatment. SIGNIFICANCE: These results suggest that EIM, a painless, non-invasive measure, can provide a useful quantitative metric in CD evaluation and deserves further study. Published by Elsevier Ireland Ltd.

Entities:  

Mesh:

Year:  2010        PMID: 20943436      PMCID: PMC3044213          DOI: 10.1016/j.clinph.2010.09.013

Source DB:  PubMed          Journal:  Clin Neurophysiol        ISSN: 1388-2457            Impact factor:   3.708


  31 in total

1.  Electrical impedance myography in the bedside assessment of inflammatory myopathy.

Authors:  A Tarulli; G J Esper; K S Lee; R Aaron; C A Shiffman; S B Rutkove
Journal:  Neurology       Date:  2005-08-09       Impact factor: 9.910

2.  Test-retest reproducibility of 50 kHz linear-electrical impedance myography.

Authors:  Seward B Rutkove; Kyungmouk S Lee; Carl A Shiffman; Ronald Aaron
Journal:  Clin Neurophysiol       Date:  2006-04-27       Impact factor: 3.708

3.  CDIP-58 can measure the impact of botulinum toxin treatment in cervical dystonia.

Authors:  S J Cano; J C Hobart; M Edwards; R Fitzpatrick; K Bhatia; A J Thompson; T T Warner
Journal:  Neurology       Date:  2006-12-26       Impact factor: 9.910

4.  Prevalence of cervical dystonia and spasmodic torticollis in the United States general population.

Authors:  J Jankovic; J Tsui; C Bergeron
Journal:  Parkinsonism Relat Disord       Date:  2007-04-17       Impact factor: 4.891

5.  Electrical impedance myography to assess outcome in amyotrophic lateral sclerosis clinical trials.

Authors:  Seward B Rutkove; Hui Zhang; David A Schoenfeld; Elizabeth M Raynor; Jeremy M Shefner; Merit E Cudkowicz; Anne B Chin; Ronald Aaron; Carl A Shiffman
Journal:  Clin Neurophysiol       Date:  2007-09-25       Impact factor: 3.708

6.  Teaching tape for the motor section of the Toronto Western Spasmodic Torticollis Scale.

Authors:  C L Comella; G T Stebbins; C G Goetz; T A Chmura; S B Bressman; A E Lang
Journal:  Mov Disord       Date:  1997-07       Impact factor: 10.338

7.  Assessing neuromuscular disease with multifrequency electrical impedance myography.

Authors:  Gregory J Esper; Carl A Shiffman; Ronald Aaron; Kyungmouk S Lee; Seward B Rutkove
Journal:  Muscle Nerve       Date:  2006-11       Impact factor: 3.217

8.  Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.

Authors:  D M Simpson; A Blitzer; A Brashear; C Comella; R Dubinsky; M Hallett; J Jankovic; B Karp; C L Ludlow; J M Miyasaki; M Naumann; Y So
Journal:  Neurology       Date:  2008-05-06       Impact factor: 9.910

9.  The effects of botulinum toxin type A on muscle blood perfusion and metabolism.

Authors:  Damir B Matic; Ting Y Lee; R Glenn Wells; Bing S Gan
Journal:  Plast Reconstr Surg       Date:  2007-12       Impact factor: 4.730

Review 10.  Treatment of dystonia with deep brain stimulation.

Authors:  Jill L Ostrem; Philip A Starr
Journal:  Neurotherapeutics       Date:  2008-04       Impact factor: 7.620

View more
  4 in total

1.  Secondary atlantoaxial subluxation in isolated cervical dystonia-a case report.

Authors:  Eric Chun-Pu Chu; Fa-Sain Lo; Amiya Bhaumik
Journal:  AME Case Rep       Date:  2020-04-30

2.  Electrical impedance myography as a biomarker to assess ALS progression.

Authors:  Seward B Rutkove; James B Caress; Michael S Cartwright; Ted M Burns; Judy Warder; William S David; Namita Goyal; Nicholas J Maragakis; Lora Clawson; Michael Benatar; Sharon Usher; Khema R Sharma; Shiva Gautam; Pushpa Narayanaswami; Elizabeth M Raynor; Mary Lou Watson; Jeremy M Shefner
Journal:  Amyotroph Lateral Scler       Date:  2012-06-07

3.  Performing In Vivo and Ex Vivo Electrical Impedance Myography in Rodents.

Authors:  Marie Mortreux; Janice A Nagy; Haowen Zhong; Dong-Min Sung; Holly A Concepcion; Melanie Leitner; Laura Dalle Pazze; Seward B Rutkove
Journal:  J Vis Exp       Date:  2022-06-08       Impact factor: 1.424

4.  The neuromuscular impact of symptomatic SMN restoration in a mouse model of spinal muscular atrophy.

Authors:  W Arnold; Vicki L McGovern; Benjamin Sanchez; Jia Li; Kaitlyn M Corlett; Stephen J Kolb; Seward B Rutkove; Arthur H Burghes
Journal:  Neurobiol Dis       Date:  2015-12-28       Impact factor: 5.996

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.